Clinical trial
A Prospective Multicenter Registry of Golimumab in Chinese Patients With Rheumatoid Arthritis
NCT04188249 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Registry of Golimumab in Chinese Patients With Rheumatoid Arthritis
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2019
- Completion date
- March 1, 2021
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.